GW
Gregory M Weinhoff (Chief Business Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Centessa Pharmaceuticals plc (CNTA). The largest single filing was $1.9M of CNTA (73,196 sh across 2 lots, as filed), executed Mar 13. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.6M
shares × price, as filed
Last traded
Mar 26
Filed Mar 26
Median ADV $76.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $3.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
CNTA
Centessa Pharmaceuticals plc
CNTA · 0 buys · 11 sells
11 filings
Recent filings
CNTASALE
Centessa Pharmaceuticals plc
View filing →
$193K11,742 sh × $16.47
Exec Jan 27 2025
Filed Jan 28 2025 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $170K
10,000 sh × $17.04
Exec Dec 26 2024
Filed Dec 26 2024 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $177K
10,000 sh × $17.66
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET CNTASALE Centessa Pharmaceuticals plc View filing → $181K
11,742 sh × $15.38
Exec Oct 25 2024
Filed Oct 25 2024 · 5:30 PM ET